HDAC9 and cancer: Inducing senescence—a quiescent, non‐dividing cell state—in cancerous cells is a desired outcome for cancer therapy, and a number of studies have shown HDAC inhibitors to cause various cancer cells to senesce (Lorenz et al, 2011; Vargas et al, 2014; Venkatesh et al, 2015).